Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

A high-throughput analysis of the IDH1(R132H) protein expression in pituitary adenomas

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Semen quality in hypogonadal acromegalic patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Acute presentation of craniopharyngioma in children and adults in a Danish national cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The metabolic consequences of thyroxine replacement in adult hypopituitary patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Cardiac effects of 3 months treatment of acromegaly evaluated by magnetic resonance imaging and B-type natriuretic peptides

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Prolonging fixation time of an alternative fixative to formalin for dermatological samples using standard laboratory protocols

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Regional Differences in Neuroinflammation-Associated Gene Expression in the Brain of Sporadic Creutzfeldt-Jakob Disease Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The molecular profile of mucosal melanoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Olivera Casar-Borota
  • Kristin Astrid Berland Øystese
  • Magnus Sundström
  • Linea Melchior
  • Vera Popovic
Vis graf over relationer

PURPOSE: Inactivating mutations of isocitrate dehydrogenase (IDH) 1 and 2, mitochondrial enzymes participating in the Krebs tricarboxylic acid cycle play a role in the tumorigenesis of gliomas and also less frequently in acute myeloid leukemia and other malignancies. Inhibitors of mutant IDH1 and IDH2 may potentially be effective in the treatment of the IDH mutation driven tumors. Mutations in the succinate dehydrogenase, the other enzyme complex participating in the Krebs cycle and electron transfer of oxidative phosphorylation occur in the paragangliomas, gastrointestinal stromal tumors, and occasionally in the pituitary adenomas. We aimed to determine whether the IDH1(R132H) mutation, the most frequent IDH mutation in human malignancies, occurs in pituitary adenomas.

METHODS: We performed immunohistochemical analysis by using a monoclonal anti-IDH1(R132H) antibody on the tissue microarrays containing specimens from the pituitary adenomas of different hormonal types from 246 patients. In positive samples, the status of the IDH1 gene was further examined by molecular genetic analyses.

RESULTS: In all but one patient, there was no expression of mutated IDH1(R132H) protein in the tumor cells by immunohistochemistry. Only one patient with a recurring clinically non-functioning gonadotroph adenoma demonstrated IDH1(R132H)-immunostaining in both the primary tumor and the recurrence. However, no mutation in the IDH1 gene was detected using different molecular genetic analyses.

CONCLUSION: IDH1(R132H) mutation occurs only exceptionally in pituitary adenomas and does not play a role in their pathogenesis. Patients with pituitary adenomas do not seem to be candidates for treatment with the inhibitors of mutant IDH1.

OriginalsprogEngelsk
TidsskriftPituitary
Vol/bind19
Udgave nummer4
Sider (fra-til)407-14
Antal sider8
ISSN1386-341X
DOI
StatusUdgivet - aug. 2016

ID: 49948141